MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Thermo Fisher Scientific Depreciation & Amortization 2011-2026 | TMO
Annual Depreciation & Amortization Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.05 B | 1.16 B | 1.07 B | 986 M | 831 M | 658 M | 564 M | 2.27 B | 2.03 B | 1.76 B | 1.69 B | 1.68 B | 1 B | 984 M | 864 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.27 B | 564 M | 1.24 B |
Quarterly Depreciation & Amortization Thermo Fisher Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 227 M | 256 M | 276 M | 291 M | 276 M | 285 M | - | - | 253 M | - | 730 M | - | 250 M | - | 614 M | - | 198 M | - | 467 M | 306 M | 149 M | - | 416 M | 275 M | 133 M | - | 132 M | 130 M | 575 M | - | 1.46 B | 942 M | 465 M | - | 1.28 B | 851 M | 416 M | - | 1.26 B | 836 M | 416 M | - | 1.26 B | 800 M | 366 M | - | 751 M | 500 M | 251 M | - | 729 M | 484 M | 242 M | - | 614 M | 385 M | 184 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.46 B | 130 M | 506 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
1.11 M | $ 1.29 | -21.17 % | $ 1.72 M |  USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 15.7 | -3.03 % | $ 475 M | USA |
 |
Agilent Technologies
A
|
321 M | $ 111.7 | -1.38 % | $ 34 B | USA |
 |
Castle Biosciences
CSTL
|
40.8 M | $ 19.13 | 1.32 % | $ 555 M | USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
354 M | $ 142.54 | -0.49 % | $ 22.7 B | USA |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.76 | -2.22 % | $ 7.79 M | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 19.97 | -2.54 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 93.91 | -2.86 % | $ 6.34 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 031.64 | -0.99 % | $ 21.3 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 3.58 | -1.1 % | $ 332 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 415.27 | -0.93 % | $ 12 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
NeoGenomics
NEO
|
36.1 M | $ 8.24 | -1.44 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 18.62 | -1.64 % | $ 417 M | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 150.85 | -5.2 % | $ 7.48 B | USA |
 |
Natera
NTRA
|
16.7 M | $ 186.36 | -5.36 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 25.23 | -1.06 % | $ 23.9 B |  Niderland |
 |
Senseonics Holdings
SENS
|
1.51 M | $ 5.77 | -0.86 % | $ 241 M | USA |
 |
Guardant Health
GH
|
39.7 M | $ 94.92 | -3.79 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
10 M | $ 6.36 | -5.22 % | $ 568 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 116.38 | -0.61 % | $ 9.6 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
2.02 M | $ 53.01 | 0.04 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
87 K | $ 2.34 | -2.9 % | $ 5.38 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 250.4 | -1.43 % | $ 20.8 B | USA |
 |
Celcuity
CELC
|
167 K | $ 137.68 | 2.2 % | $ 6.44 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 49.17 | -7.14 % | $ 2.94 B | USA |
 |
Waters Corporation
WAT
|
88.1 M | $ 329.22 | -1.2 % | $ 19.6 B | USA |
 |
Neogen Corporation
NEOG
|
119 M | $ 8.19 | -2.85 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 186.61 | -0.71 % | $ 20.7 B | USA |